… cancer immunotherapy Keytruda stands as perhaps the most consequential patent … cancer drug launches in recent history, making its patent … in areas like gene therapy, cell therapy … must now simultaneously manage patent expirations, biosimilar competition …

… genome architecture, genetic variations, gene expression patterns, and epigenetic modifications … to the American Cancer Society, lung cancer encompassing both small cell … range of globally commercialized, patent-protected formulations and techniques used …

… CSF, revealing new insights into gene-to-protein correlations, novel biology … such as diabetes, hypertension, and cancer. The SG100K study will be … .com/legal/salesterms. Patent and License Information: standardbio.com …

… 3SBio in May for a cancer drug Pfizer sees as critical … gene editing and structural biology. Chinese researchers have also filed more patents …

… cancer (mCRPC), with or without homologous recombination repair (HRR) gene … that have recently lost patent protection or that … risks to our products, patents and other intellectual property, … ; (ii) claims of patent infringement, including asserted and…

… 2L and 3L+ metastatic colorectal cancer (mCRC) enrolling; mCRC initial … a neuregulin 1 (NRG1) gene fusion who have disease … -cell engagers using Merus’ patented Triclonics® platform. Under the … our proprietary technology; our patents may be found invalid, …

… to discontinue coverage of multi-gene panel pharmacogenetic testing, including … PGx = Pharmacogenomics Product Categories: Hereditary Cancer – MyRisk, BRACAnalysis, BRACAnalysis CDx Tumor … s tests; the risk of patent-infringement claims or challenges to …

… diseases, CNS, cell and gene therapies, and infectious diseases … based company dedicated to cancer research and treatment, … prevention and treatment of cancer through pioneering research … exclusive worldwide license to patented technology that targets …

… region, which contains essential genes for ovarian development and … bilateral tubal spill, indicating patent fallopian tubes. Minimal intraoperative … as it contains key genes essential for ovarian development … is crucial to reducing cancer risk in females with …

… the short life of their patent, thereby limiting what companies will … important, and the research in gene therapy a wildly important component … a drug to treat cancer – melanoma (skin cancer, specifically – stated that “the …